Analysts (Still) In Love With Symantec Corporation (SYMC), Exelixis, Inc. (EXEL)

2 analysts out of 28 Wall Street brokerage firms rate Symantec Corporation (NASDAQ:SYMC) as a Buy, while 2 see it as a Sell. The rest 24 describe it as a Hold. SYMC stock traded higher to an intra-day high of $22.34. At one point in session, its potential discontinued and the price was down to lows at $21.43. Analysts have set SYMC’s consensus price at $22.6, effectively giving it a 1.3% projection on returns. Should the projected estimates be met, then the stock will likely hit its highest price at $28 (up 25.5% from current price levels). SYMC has a 22.2% ROE, higher than the -122.57% average for the industry. The average ROE for the sector is 17.89%.

It is expected that in Dec 2018 quarter SYMC will have an EPS of $0.26, while that of Mar 2019 is projected at $0.23. It means that there could be a -31.58% and -11.54% growth in the two quarters respectively. Yearly earnings are expected to rise by 5.26% to about $1. As for the coming year, growth will be about 18%, lifting earnings to $1.18. RSI after the last trading period was 55.74. SYMC recorded a change of -0.84% over the past week and returned 12.62% over the last three months while the SYMC stock’s monthly performance revealed a shift in price of 11.44%. The year to date (YTD) performance stands at -20.49%, and the bi-yearly performance specified an activity trend of 4.74% while the shares have moved -18.7% for the past 12 months.

Symantec Corporation (SYMC) currently trades at $22.31, which is higher by 1.59% its previous price. It has a total of 652.47 million outstanding shares, with an ATR of around 0.81. The company’s stock volume dropped to 6.23 million, worse than 8.41 million that represents its 50-day average. A 5-day decrease of about -0.84% in its price means SYMC is now -20.49% lower on year-to-date. The shares have surrendered $43380.69 since its $29.73 52-week high price recorded on 9th of January 2018. Overall, it has seen a growth rate of -18.7 over the last 12 months. The current price per share is $4.82 above the 52 week low of $17.49 set on 30th of October 2018.

Symantec Corporation (NASDAQ:SYMC)’s EPS was $0.42 as reported for the September quarter. In comparison, the same quarter a year ago had an EPS of $0.4. That means that its growth in general now stands at 5%. Therefore, a prediction of $0.33 given by the analysts brought a positive surprise of 27%. SYMC Sep 18 quarter revenue was $1.18 billion, compared to $1.28 billion recorded in same quarter last year, giving it a -7% growth rate. The company’s -$0.1 billion revenue decline that quarter surprised Wall Street and investors will need to consider this as they assess the stock.

Exelixis, Inc. (NASDAQ:EXEL) shares appreciated 2.63% over the last trading period, taking overall 5-day performance up to 7%. SYMC’s price now at $21.1 is greater than the 50-day average of $17.15. Getting the trading period increased to 200 days, the stock price was seen at $20.01 on average. The general public currently hold control of a total of 293.85 million shares, which is the number publicly available for trading. The total of shares that it has issued to investors is 298.42 million. The company’s management holds a total of 0.9%, while institutional investors hold about 79.2% of the remaining shares. SYMC share price finished last trade 16.05% above its 20 day simple moving average and its upbeat gap from 200 day simple moving average is 5.23%, while closing the session with 23.58% distance from 50 day simple moving average.

Exelixis, Inc. (EXEL) shares were last observed trading -34.47% down since January 04, 2018 when the peak of $32.2 was hit. Last month’s price growth of 18.47% puts EXEL performance for the year now at -30.59%. Consequently, the shares price is trending higher by 57.23%, a 52-week worst price since Oct. 29, 2018. However, it is regaining value with 9.84% in the last 6 months. From a technical perspective, it appears more likely that the stock will experience a Bull Run market as a result of the strong support seen recently between $19.23 and $20.16. The immediate resistance area is now $21.57 Williams’s%R (14) for EXEL moved to 11.67 while the stochastic%K points at 81.7.

EXEL’s beta is 2.26; meaning investors could reap higher returns, although it also poses higher risks. The company allocated $1.18 per share from its yearly profit to its outstanding shares. Its last reported revenue is $225.4 million, which was 48% versus $152.51 million in the corresponding quarter last year. The EPS for Sep 18 quarter came in at $0.41 compared to $0.26 in the year-ago quarter and had represented 58% year-over-year earnings per share growth. EXEL’s ROA is 43.8%, higher than the -1.12% industry average. Although a more robust percentage would be better, consideration is given to how well peers within the industry performed. Companies within the sector had an ROA of 11.5%.

Estimated quarterly earnings for Exelixis, Inc. (NASDAQ:EXEL) are around $0.25 per share in three months through December with $0.27 also the estimate for March quarter of the fiscal year. It means the growth is estimated at 108.33% and -27.03%, respectively. Analysts estimate full-year growth to be 154.9%, the target being $1.3 a share. The upcoming year will see an increase in growth by percentage to -3.85%, more likely to see it hit the $1.25 per share. The firm’s current profit margin over the past 12 months is 49.5%. EXEL ranks higher in comparison to an average of -697.14% for industry peers; while the average for the sector is 2.16%.